Advertisement

Index by author

December 01, 2019; Volume 96,Issue 6

  1. De Esch, Iwan

    1. Open Access
      Modulators of CXCR4 and CXCR7/ACKR3 Function
      Ilze Adlere, Birgit Caspar, Marta Arimont, Sebastian Dekkers, Kirsten Visser, Jeffrey Stuijt, Chris de Graaf, Michael Stocks, Barrie Kellam, Stephen Briddon, Maikel Wijtmans, Iwan de Esch, Stephen Hill and Rob Leurs
      Molecular Pharmacology December 2019, 96 (6) 737-752; DOI: https://doi.org/10.1124/mol.119.117663

  2. De Graaf, Chris

    1. Open Access
      Chemokine Receptor Crystal Structures: What Can Be Learned from Them?
      Marta Arimont, Carsten Hoffmann, Chris de Graaf and Rob Leurs
      Molecular Pharmacology December 2019, 96 (6) 765-777; DOI: https://doi.org/10.1124/mol.119.117168
    2. Open Access
      Modulators of CXCR4 and CXCR7/ACKR3 Function
      Ilze Adlere, Birgit Caspar, Marta Arimont, Sebastian Dekkers, Kirsten Visser, Jeffrey Stuijt, Chris de Graaf, Michael Stocks, Barrie Kellam, Stephen Briddon, Maikel Wijtmans, Iwan de Esch, Stephen Hill and Rob Leurs
      Molecular Pharmacology December 2019, 96 (6) 737-752; DOI: https://doi.org/10.1124/mol.119.117663

  3. De Groof, Timo W.M.

    1. Open Access
      Antibodies Targeting Chemokine Receptors CXCR4 and ACKR3
      Vladimir Bobkov, Marta Arimont, Aurélien Zarca, Timo W.M. De Groof, Bas van der Woning, Hans de Haard and Martine J. Smit
      Molecular Pharmacology December 2019, 96 (6) 753-764; DOI: https://doi.org/10.1124/mol.119.116954

  4. De Haard, Hans

    1. Open Access
      Antibodies Targeting Chemokine Receptors CXCR4 and ACKR3
      Vladimir Bobkov, Marta Arimont, Aurélien Zarca, Timo W.M. De Groof, Bas van der Woning, Hans de Haard and Martine J. Smit
      Molecular Pharmacology December 2019, 96 (6) 753-764; DOI: https://doi.org/10.1124/mol.119.116954

  5. Dekkers, Sebastian

    1. Open Access
      Modulators of CXCR4 and CXCR7/ACKR3 Function
      Ilze Adlere, Birgit Caspar, Marta Arimont, Sebastian Dekkers, Kirsten Visser, Jeffrey Stuijt, Chris de Graaf, Michael Stocks, Barrie Kellam, Stephen Briddon, Maikel Wijtmans, Iwan de Esch, Stephen Hill and Rob Leurs
      Molecular Pharmacology December 2019, 96 (6) 737-752; DOI: https://doi.org/10.1124/mol.119.117663

  6. Durroux, Thierry

    1. Open Access
      Context-Dependent Signaling of CXC Chemokine Receptor 4 and Atypical Chemokine Receptor 3
      Joyce Heuninck, Cristina Perpiñá Viciano, Ali Işbilir, Birgit Caspar, Davide Capoferri, Stephen J. Briddon, Thierry Durroux, Stephen J. Hill, Martin J. Lohse, Graeme Milligan, Jean-Philippe Pin and Carsten Hoffmann
      Molecular Pharmacology December 2019, 96 (6) 778-793; DOI: https://doi.org/10.1124/mol.118.115477

  7. Fumagalli, Amos

    1. CXCR4/ACKR3 Phosphorylation and Recruitment of Interacting Proteins: Key Mechanisms Regulating Their Functional Status
      Open Access
      CXCR4/ACKR3 Phosphorylation and Recruitment of Interacting Proteins: Key Mechanisms Regulating Their Functional Status
      Amos Fumagalli, Aurélien Zarca, Maria Neves, Birgit Caspar, Stephen J. Hill, Federico Mayor, Martine J. Smit and Philippe Marin
      Molecular Pharmacology December 2019, 96 (6) 794-808; DOI: https://doi.org/10.1124/mol.118.115360
    2. The Role of ACKR3 in Breast, Lung, and Brain Cancer
      The Role of ACKR3 in Breast, Lung, and Brain Cancer
      Maria Neves, Amos Fumagalli, Jelle van den Bor, Philippe Marin, Martine J. Smit and Federico Mayor
      Molecular Pharmacology December 2019, 96 (6) 819-825; DOI: https://doi.org/10.1124/mol.118.115279

  8. Gallego, Carmen

    1. Atypical Chemokine Receptor 3 (ACKR3): A Comprehensive Overview of its Expression and Potential Roles in the Immune System
      Joyce Koenen, Françoise Bachelerie, Karl Balabanian, Géraldine Schlecht-Louf and Carmen Gallego
      Molecular Pharmacology December 2019, 96 (6) 809-818; DOI: https://doi.org/10.1124/mol.118.115329

  9. Ha, Kwon-Soo

    1. Open Access
      N-Terminal Modification of the Tetrapeptide Arg-Leu-Tyr-Glu, a Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) Antagonist, Improves Antitumor Activity by Increasing its Stability against Serum Peptidases
      Jung-A Yun, Joohwan Kim, Yi-Yong Baek, Wonjin Park, Minsik Park, Suji Kim, Taesam Kim, Seunghwan Choi, Dooil Jeoung, Hansoo Lee, Moo-Ho Won, Ji-Yoon Kim, Kwon-Soo Ha, Young-Guen Kwon and Young-Myeong Kim
      Molecular Pharmacology December 2019, 96 (6) 692-701; DOI: https://doi.org/10.1124/mol.119.117234

  10. Heasley, Lynn E.

    1. Functional RNAi Screens Define Distinct Protein Kinase Vulnerabilities in EGFR-Dependent HNSCC Cell Lines
      Trista K. Hinz, Emily K. Kleczko, Katherine R. Singleton, Jacob Calhoun, Lindsay A. Marek, Jihye Kim, Aik Choon Tan and Lynn E. Heasley
      Molecular Pharmacology December 2019, 96 (6) 862-870; DOI: https://doi.org/10.1124/mol.119.117804
« Previous (Pages : 1 2 3 4 5 6 7 8 ... 11) Next »
Back to top

In this issue

Advertisement